Nucleotide analog antiviral

This page covers all Nucleotide analog antiviral drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Viral DNA polymerase.

Targets

Viral DNA polymerase

Phase 3 pipeline (1)

• Cidofovir intravenous · Johns Hopkins Bloomberg School of Public Health · Infectious Disease / Virology
  Cidofovir is a nucleotide analog that inhibits viral DNA polymerase, preventing viral DNA replication in infected cells.

Patent intelligence

• nucleotide analog antiviral patent landscape — aggregated cliff calendar, attackable patents, originator estates